** Shares of Swedish medical equipment maker Getinge GETIb.ST fall over 6% after Q4 earnings falls short of expectations
** Co's EBITA falls 16% to SEK 1,809 million ($202 million) in the quarter, vs. company-provided consensus of SEK 1,874 million
** Getinge took a hit from tariffs and currency exchange rates over the last year, says CEO Mattias Perjos
** Co expects 2026 net sales to grow 3% to 5% organically
** "We forecast at least 5% cuts to consensus revenue and adj. EBITA expectations given the lower FY25 base, FX headwinds and we see further downside risk from tariffs, which appear to have been under-estimated by consensus" - J.P. Morgan
** Shares set for worst day since April 2025
($1 = 8.9434 Swedish crowns)
(Reporting by Agnieszka Olenska)
((Agnieszka.olenska@thomsonreuters.com))